Apr 13, 2026 01:49AM

Mar 31, 2026 11:03AM

Mar 31, 2026 07:23AM

Mar 31, 2026 06:45AM

Mar 31, 2026 06:45AM

Dec 11, 2025 07:00AM

Dec 11, 2025 07:00AM Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications 

Dec 1, 2025 06:58AM

Jun 10, 2024 07:00AM

Jun 10, 2024 06:01AM

Mar 23, 2023 04:32PM

Mar 23, 2023 04:30PM

Jan 16, 2023 09:00PM

Nov 27, 2022 08:55PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Olo, Centessa, PayPal, and Opendoor and Encourages Investors to Contact the Firm

Nov 21, 2022 09:00PM

Nov 16, 2022 08:45PM

Nov 11, 2022 09:00PM

Nov 6, 2022 09:00PM

Oct 31, 2022 09:00PM

Oct 26, 2022 09:00PM

Oct 21, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Barclays, Warner Bros., Olo, and Centessa and Encourages Investors to Contact the Firm

Oct 16, 2022 11:28PM

Oct 11, 2022 10:11PM

Oct 6, 2022 09:00PM

Oct 3, 2022 06:00AM

Oct 3, 2022 06:00AM

Jul 18, 2022 06:00AM

May 16, 2022 07:00AM Centessa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Updates

May 16, 2022 07:00AM

Apr 4, 2022 08:00AM

Mar 30, 2022 04:01PM

Mar 30, 2022 04:01PM

Feb 24, 2022 07:31AM

Feb 24, 2022 07:30AM

Feb 24, 2022 07:30AM Centessa Pharmaceuticals Doses First Subject in Global Phase 3 ACTION Study of Lixivaptan in Autosomal Dominant Polycystic Kidney Disease

Dec 7, 2021 09:00AM

Nov 29, 2021 08:01AM

Nov 15, 2021 07:00AM

Nov 15, 2021 07:00AM

Oct 4, 2021 08:02AM

Oct 4, 2021 08:00AM

Oct 4, 2021 08:00AM Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland Capital

Aug 16, 2021 07:00AM

Aug 16, 2021 07:00AM

Aug 12, 2021 03:00AM

1,160,205 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All